Your browser doesn't support javascript.
loading
Probing Mechanisms of CYP3A Time-Dependent Inhibition Using a Truncated Model System.
Wang, Xiaojing; Sun, Minghua; New, Connie; Nam, Spencer; Blackaby, Wesley P; Hodges, Alastair J; Nash, David; Matteucci, Mizio; Lyssikatos, Joseph P; Fan, Peter W; Tay, Suzanne; Chang, Jae H.
Afiliação
  • Wang X; Genentech, Inc. , 1 DNA Way, South San Francisco, California 94080, United States.
  • Sun M; Genentech, Inc. , 1 DNA Way, South San Francisco, California 94080, United States.
  • New C; Genentech, Inc. , 1 DNA Way, South San Francisco, California 94080, United States.
  • Nam S; Genentech, Inc. , 1 DNA Way, South San Francisco, California 94080, United States.
  • Blackaby WP; Genentech, Inc. , 1 DNA Way, South San Francisco, California 94080, United States.
  • Hodges AJ; Genentech, Inc. , 1 DNA Way, South San Francisco, California 94080, United States.
  • Nash D; Genentech, Inc. , 1 DNA Way, South San Francisco, California 94080, United States.
  • Matteucci M; Genentech, Inc. , 1 DNA Way, South San Francisco, California 94080, United States.
  • Lyssikatos JP; Genentech, Inc. , 1 DNA Way, South San Francisco, California 94080, United States.
  • Fan PW; Genentech, Inc. , 1 DNA Way, South San Francisco, California 94080, United States.
  • Tay S; Genentech, Inc. , 1 DNA Way, South San Francisco, California 94080, United States.
  • Chang JH; Genentech, Inc. , 1 DNA Way, South San Francisco, California 94080, United States.
ACS Med Chem Lett ; 6(8): 925-9, 2015 Aug 13.
Article em En | MEDLINE | ID: mdl-26288695
Time-dependent inhibition (TDI) of cytochrome P450 (CYP) enzymes may incur serious undesirable drug-drug interactions and in rare cases drug-induced idiosyncratic toxicity. The reactive metabolites are often generated through multiple sequential biotransformations and form adducts with CYP enzymes to inactivate their function. The complexity of these processes makes addressing TDI liability very challenging. Strategies to mitigate TDI are therefore highly valuable in discovering safe therapies to benefit patients. In this Letter, we disclose our simplified approach toward addressing CYP3A TDI liabilities, guided by metabolic mechanism hypotheses. By adding a methyl group onto the α carbon of a basic amine, TDI activities of both the truncated and full molecules (7a and 11) were completely eliminated. We propose that truncated molecules, albeit with caveats, may be used as surrogates for full molecules to investigate TDI.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2015 Tipo de documento: Article